Vasa Therapeutics

Overview

Right Mechanism. Right Chemistry. Real Patient Impact.. Transformative therapies for diseases of cardiovascular, neuromuscular and age-related disorders.

Funding and backers

Total raised
$6M
1 round on record
Latest round
$6M
Seed · Jan 2024 · 2 yr ago
Team
11-50
employees, estimated range
Backers
1
i&i Bio
The money's age
Long since its last round
34 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Jan 4, 2024 Raised a round Seed $6M · led by Orphinic Scientific SA · Pulse 2.0
Funding rounds
RoundDateAmountInvestorsSource
Seed Jan 2024 $6M Orphinic Scientific SA lead Pulse 2.0
Backed byfrom the funds' portfolios and accelerator catalogs
i&i Bio fund
Investors in similar startupsfunds that back the companies most like this one
Healthspan Capital
backs Oisinbio, Vincere Bio logo
Khosla Ventures
backs Ukko
GV
backs Cardurion
NEA
backs Cardurion
RA Capital Management
backs Forward Therapeutics
Western Technology Investment
backs Ukko
Similar startupsby what they do, their industry and backers
Forward TherapeuticsVenture round $50M · 2 yr ago
Forward, by Design.. Novel chemistry. Proven pathways. Designed for patient impact.
CardurionSeries B $260M · 2 yr ago
Transforming the treatment of cardiovascular disease and heart failure.
Biokier11-50 employees
About Us BioKier Inc. is an early-stage pharmaceutical company developing new proprietary medical foods and drugs for diabetes and related…
Vincere Bio logo11-50 employees
Highlights. Vincere makes new medicines to treat age-related diseases including Parkinson's and Kidney disease.
JuvlabsConvertible Note $9.5M · 5 yr ago · Founded 2017 · 51-200 employees
We extend healthy lifespan through developing innovative medicines that target core aging mechanisms to not only treat but prevent…
Revel PharmaceuticalsVenture round $5.8M · 4 yr ago · Founded 2019 · 11-50 employees
Revel Pharmaceuticals develops therapeutic enzymes that reverse age-related damage in structural tissue, targeting the molecular root of…

Financials

Total raised
$6M
Latest round
Seed
Funding rounds
1
Funding rounds
Round Announced Amount
Seed 2024 $6M Details

Connections

List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors1
i&i BioVia a fund
23 portfolio companies: Středisko společných činností AV ČR, Česká spořitelna, Cuip and 20 more
Report a mistake